NCT07453394 2026-03-06QLS5132 Combination Therapy in Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting626 enrolled
NCT07174908 2026-03-03A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C MutationInxMed (Shanghai) Co., Ltd.Phase 3 Recruiting400 enrolled